Cardiome Pharma Corp. (T:COM)

Business Focus: Biopharmaceuticals

This company is also listed in the United States as CRME on the NASDAQ. Click here to see if there are any SEC insider filings on insidertracking.com.
Log in or sign up for a free account to add this stock to your watch list.

Insider Chart - Past 6 Months


Insider Filings

Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by transaction date) for COM within the last 6 months ?
Amended Filing
As of 11:59pm ET February 9th, 2016
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 30/15 Sep 25/15 Meyer, Robert James Direct Ownership Options 50 - Grant of options 10,100 $9.74
USD
Sep 30/15 Aug 31/15 Meyer, Robert James Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Aug 12/15 Jun 22/15 Dean, David Cameron Peter Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report    
Aug 12/15 Jun 22/15 Dean, David Cameron Peter Direct Ownership Options 00 - Opening Balance-Initial SEDI Report 50,000  
Cardiome Pharma Corp. Insider Report Only $9.99